01405nas a2200193   4500000000100000008004100001260003400042653001800076653001900094653002100113653001600134653003300150100001600183245012600199856011000325300000600435520074500441022002501186       2025                            d  bOxford University Press (OUP)10aAnthelminthic10aHealth systems10aMedical inequity10aPaediatrics10aPreventive chemotherapy (PC)1 aStothard JR00aSchistosomiasis treatment in young children: a welcome step towards deployment of the paediatric praziquantel formulation  uhttps://academic.oup.com/inthealth/advance-article-pdf/doi/10.1093/inthealth/ihae094/61616811/ihae094.pdf  a33 a<p>It is an awkward fact that effective public health control of schistosomiasis in Africa has yet to deliver a fully comprehensive intervention for appropriate anthelmintic treatment of those preschool-age children and infants with active infection(s) and/or insidious disease. Over the last decade, despite the steady progress of the Pediatric Praziquantel Consortium in developing a monoenantiomeric oral dispersible tablet, future challenges remain in securing its deployment and implementation at scale. This commentary provides a forward-looking critique for the international community, reminding us of this unfortunate treatment gap, and seeks to encourage commensurate action on ameliorating this overlooked medical inequity.</p>
  a1876-3413, 1876-3405